Clindamycin Phosphate USP Powder For Compounding (API)

Clindamycin Phosphate USP (United States Pharmacopeia) powder is a medicated form of clindamycin that is used as the active pharmaceutical ingredient (API) in compounding medication. It is a semisynthetic antibiotic that is effective against a variety of bacterial infections, including respiratory, skin, and soft tissue infections.

Clindamycin Phosphate USP is a white to off-white, hygroscopic, crystalline powder. It is odorless to practically odorless.

Compounding refers to the process of creating customized medications for individual patients based on their specific needs, such as dosage strength or allergies to certain ingredients. Clindamycin Phosphate USP powder is often used by compounding pharmacists to create topical and oral medication formulations for patients who cannot take commercially available versions of the medication due to various reasons, such as allergies or sensitivities.

The USP designation ensures that the clindamycin phosphate powder meets certain quality standards set by the United States Pharmacopeia, including purity, potency, and quality control measures. This assures healthcare providers and patients that the medication is safe, effective, and manufactured according to strict guidelines.

Overall, clindamycin phosphate USP powder for compounding is an important component for creating personalized medication solutions for patients and plays an essential role in the treatment of a variety of bacterial infections.